SCHEMBL9717558

SCHEMBL9717558

CC/C(=C\c1ccc(OC2(C(=O)NCCC(=O)O)CCC2)c(Cl)c1Cl)[N+](=O)[O-]

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.33
CTSK P43235 4/20 0.32
SIRT5 Q9NXA8 1/20 0.31
ITGAL P20701 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9717563 1.00 NPSR1 (0.33) NPSR1CTSKSIRT5ITGAL
SCHEMBL9717501 0.91 MEN1 (0.31) NPSR1
SCHEMBL9717553 0.91 MEN1 (0.31) NPSR1
SCHEMBL9717645 0.90 MEN1 (0.30) NPSR1
SCHEMBL9717643 0.86
SCHEMBL9717522 0.85 MEN1 (0.30) NPSR1
SCHEMBL9717517 0.85 MEN1 (0.30) NPSR1
SCHEMBL9717529 0.81
SCHEMBL9717540 0.81
SCHEMBL9717538 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0240256-B1 COMPOUNDS USEFUL IN TREATING SICKLE CELL ANEMIA MERCK & CO. INC. (US) 1992-04-29 EP disclosed
US-4751244-A NITROALKENYL CARBOXYLIC ACIDS MERCK & CO., INC. (US) 1988-06-14 US disclosed
EP-0240256-A2 Compounds useful in treating sickle cell anemia MERCK & CO. INC. (US) 1987-10-07 EP disclosed